Artikkelit, joihin on yleisen käytön mandaatti - Doug LangbehnLisätietoja
Ei saatavilla missään: 3
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ...
The Lancet Neurology 10 (1), 31-42, 2011
Mandaatit: National Institute of Health and Medical Research, France
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
R Reilmann, A McGarry, ID Grachev, JM Savola, B Borowsky, E Eyal, ...
The Lancet Neurology 18 (2), 165-176, 2019
Mandaatit: US National Institutes of Health, German Research Foundation, UK Medical …
Huntington's disease progression: a population modeling approach to characterization using clinical rating scales
W Sun, D Zhou, JH Warner, DR Langbehn, G Hochhaus, Y Wang
The Journal of Clinical Pharmacology 60 (8), 1051-1060, 2020
Mandaatit: Wellcome Trust
Saatavilla jossain: 89
Huntington disease: natural history, biomarkers and prospects for therapeutics
CA Ross, EH Aylward, EJ Wild, DR Langbehn, JD Long, JH Warner, ...
Nature Reviews Neurology 10 (4), 204-216, 2014
Mandaatit: US National Institutes of Health
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ...
The Lancet Neurology 8 (9), 791-801, 2009
Mandaatit: US National Institutes of Health
Detection of Huntington’s disease decades before diagnosis: the Predict-HD study
JS Paulsen, DR Langbehn, JC Stout, E Aylward, CA Ross, M Nance, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (8), 874-880, 2008
Mandaatit: US National Institutes of Health, Howard Hughes Medical Institute
CAG‐repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches
DR Langbehn, MR Hayden, JS Paulsen, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010
Mandaatit: US National Institutes of Health
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
Mandaatit: US National Institutes of Health, Government of Spain
Neurocognitive signs in prodromal Huntington disease.
JC Stout, JS Paulsen, S Queller, AC Solomon, KB Whitlock, JC Campbell, ...
Neuropsychology 25 (1), 1, 2011
Mandaatit: US National Institutes of Health
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ...
The Lancet Neurology 16 (8), 601-609, 2017
Mandaatit: Knut and Alice Wallenberg Foundation, Swedish Research Council, UK Medical …
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
Mandaatit: UK Medical Research Council, National Institute for Health Research, UK …
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients
EJ Wild, R Boggio, D Langbehn, N Robertson, S Haider, JRC Miller, ...
The Journal of clinical investigation 125 (5), 1979-1986, 2015
Mandaatit: US National Institutes of Health, Swedish Research Council, UK Biotechnology …
Longitudinal change in regional brain volumes in prodromal Huntington disease
EH Aylward, PC Nopoulos, CA Ross, DR Langbehn, RK Pierson, JA Mills, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (4), 405-410, 2011
Mandaatit: US National Institutes of Health, Howard Hughes Medical Institute
Striatal and white matter predictors of estimated diagnosis for Huntington disease
JS Paulsen, PC Nopoulos, E Aylward, CA Ross, H Johnson, VA Magnotta, ...
Brain research bulletin 82 (3-4), 201-207, 2010
Mandaatit: US National Institutes of Health
Fiber intake and survival after colorectal cancer diagnosis
M Song, K Wu, JA Meyerhardt, S Ogino, M Wang, CS Fuchs, ...
JAMA oncology 4 (1), 71-79, 2018
Mandaatit: US National Institutes of Health, UK Medical Research Council, National …
“Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: evidence of early lack of awareness
K Duff, JS Paulsen, LJ Beglinger, DR Langbehn, C Wang, JC Stout, ...
The Journal of neuropsychiatry and clinical neurosciences 22 (2), 196-207, 2010
Mandaatit: US National Institutes of Health, Howard Hughes Medical Institute
Mild cognitive impairment in prediagnosed Huntington disease
K Duff, J Paulsen, J Mills, LJ Beglinger, DJ Moser, MM Smith, D Langbehn, ...
Neurology 75 (6), 500-507, 2010
Mandaatit: US National Institutes of Health, Howard Hughes Medical Institute
Earliest functional declines in Huntington disease
LJ Beglinger, JJF O'Rourke, C Wang, DR Langbehn, K Duff, JS Paulsen, ...
Psychiatry research 178 (2), 414-418, 2010
Mandaatit: US National Institutes of Health
Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior
MW Coryell, AM Wunsch, JM Haenfler, JE Allen, M Schnizler, AE Ziemann, ...
Journal of Neuroscience 29 (17), 5381-5388, 2009
Mandaatit: US National Institutes of Health
Cerebral cortex structure in prodromal Huntington disease
PC Nopoulos, EH Aylward, CA Ross, HJ Johnson, VA Magnotta, AR Juhl, ...
Neurobiology of disease 40 (3), 544-554, 2010
Mandaatit: US National Institutes of Health
Tietokoneohjelma arvioi ja määrittää julkaisu- ja rahoitustiedot automaattisesti